Bloch Fleshes Out Long-term NSF Budget

WASHINGTON—Director Erich Bloch, under congressional prodding last month, predicted that the National Science Foundation will come to grips in the next five years with many of the major problems facing American science. Bloch used the annual round of hearings on NSF's request for funding to flesh out the administration's wish to double the agency's budget, to $3.2 billion, by 1992. That financial goal is part of an attempt by Bloch, a former IBM vice president, to graft a corporate approac

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Bloch used the annual round of hearings on NSF's request for funding to flesh out the administration's wish to double the agency's budget, to $3.2 billion, by 1992. That financial goal is part of an attempt by Bloch, a former IBM vice president, to graft a corporate approach to long-range planning onto an agency that must delay final decisions until Congress approves its budget each fall.

The atmosphere surrounding Bloch's testimony before the House subcommittee that authorizes the NSF's budget was noticeably warmer than the combative air marking his appearances before the appropriations panels. In gentle questioning by panel chairman Rep. Doug Waigren (D-Pa.), Bloch spelled out in unusual detail his image of NSF if its budget were doubled by 1992. He noted that its initial request to the Office of Management and Budget was for a 33 percent increase next year, and a doubling within three years.

"I hope ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Jeffrey Mervis

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours